Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition.

Total body irradiation (TBI) can induce lethal myelosuppression, due to the sensitivity of proliferating hematopoietic stem/progenitor cells (HSPCs) to ionizing radiation (IR). No effective therapy exists to mitigate the hematologic toxicities of TBI. Here, using selective and structurally distinct small molecule inhibitors of cyclin-dependent kinase 4 (CDK4) and CDK6, we have demonstrated that selective cellular quiescence increases radioresistance of human cell lines in vitro and mice in vivo. Cell lines dependent on CDK4/6 were resistant to IR and other DNA-damaging agents when treated with CDK4/6 inhibitors. In contrast, CDK4/6 inhibitors did not protect cell lines that proliferated independently of CDK4/6 activity. Treatment of wild-type mice with CDK4/6 inhibitors induced reversible pharmacological quiescence (PQ) of early HSPCs but not most other cycling cells in the bone marrow or other tissues. Selective PQ of HSPCs decreased the hematopoietic toxicity of TBI, even when the CDK4/6 inhibitor was administered several hours after TBI. Moreover, PQ at the time of administration of therapeutic IR to mice harboring autochthonous cancers reduced treatment toxicity without compromising the therapeutic tumor response. These results demonstrate an effective method to mitigate the hematopoietic toxicity of IR in mammals, which may be potentially useful after radiological disaster or as an adjuvant to anticancer therapy.

[1]  P. Mosesso,et al.  Relationship between chromatin structure, DNA damage and repair following X-irradiation of human lymphocytes. , 2010, Mutation research.

[2]  S. Kenney,et al.  Hsp90 inhibitors: a potential treatment for latent EBV infection? , 2010, Cell cycle.

[3]  D. Hunting,et al.  DNA interstrand cross-links induced by ionizing radiation: an unsung lesion. , 2010, Mutation research.

[4]  Xiaofeng Jiang,et al.  Tip60: Connecting chromatin to DNA damage signaling , 2010, Cell cycle.

[5]  L. Meijer,et al.  Cyclin-dependent kinase inhibitors: a survey of recent patent literature , 2010, Expert opinion on therapeutic patents.

[6]  W. Herr,et al.  E2F1 mediates DNA damage and apoptosis through HCF‐1 and the MLL family of histone methyltransferases , 2009, The EMBO journal.

[7]  J. Parvin,et al.  Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage. , 2009, Molecular cell.

[8]  Stephen P. Jackson,et al.  Human CtIP Mediates Cell Cycle Control of DNA End Resection and Double Strand Break Repair*S⃞ , 2009, Journal of Biological Chemistry.

[9]  J. Weiss,et al.  History and development of radiation-protective agents , 2009, International journal of radiation biology.

[10]  S. Marinopoulos,et al.  Treatment of Growing Teratoma Syndrome , 2009 .

[11]  Keith W. Caldecott,et al.  Single-strand break repair and genetic disease , 2008, Nature Reviews Genetics.

[12]  Joseph A. DiDonato,et al.  An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models , 2008, Science.

[13]  Shenghui He,et al.  Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU , 2007, Nature.

[14]  Jian Wang,et al.  Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. , 2007, Journal of the National Cancer Institute.

[15]  K. Wilner,et al.  A phase I dose escalation trial of a daily oral CDK 4/6 inhibitor PD-0332991 , 2007 .

[16]  D. Carrasco,et al.  Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. , 2007, Cancer research.

[17]  N. Sharpless,et al.  Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma. , 2007, Cancer research.

[18]  P. Fenaux,et al.  Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Nader Fotouhi,et al.  Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity. , 2006, Journal of medicinal chemistry.

[20]  Kum Kum Khanna,et al.  Cyclin-dependent kinase 2 functions in normal DNA repair and is a therapeutic target in BRCA1-deficient cancers. , 2006, Cancer research.

[21]  G. Shapiro,et al.  Cyclin-dependent kinase pathways as targets for cancer treatment. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  P. Olive,et al.  The comet assay: a method to measure DNA damage in individual cells , 2006, Nature Protocols.

[23]  J. Haveman,et al.  Clonogenic assay of cells in vitro , 2006, Nature Protocols.

[24]  Irving L. Weissman,et al.  Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates , 2005, The Journal of experimental medicine.

[25]  S. Morrison,et al.  Supplemental Experimental Procedures , 2022 .

[26]  D. W. Fry,et al.  Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6. , 2005, Journal of medicinal chemistry.

[27]  M. Malumbres,et al.  Revisiting the “Cdk-Centric” View of the Mammalian Cell Cycle , 2005, Cell cycle.

[28]  G. Enders,et al.  Cdk inhibition in human cells compromises chk1 function and activates a DNA damage response. , 2005, Cancer research.

[29]  James M. Roberts,et al.  Living with or without cyclins and cyclin-dependent kinases. , 2004, Genes & development.

[30]  N. Pryer,et al.  Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. , 2004, Molecular cancer therapeutics.

[31]  K. Akashi,et al.  Mouse Development and Cell Proliferation in the Absence of D-Cyclins , 2004, Cell.

[32]  Pierre Dubus,et al.  Mammalian Cells Cycle without the D-Type Cyclin-Dependent Kinases Cdk4 and Cdk6 , 2004, Cell.

[33]  Daohong Zhou,et al.  Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. , 2003, Cancer research.

[34]  Huichen Wang,et al.  DNA damage checkpoint control in cells exposed to ionizing radiation , 2003, Oncogene.

[35]  L. Chin,et al.  Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo , 2003, Oncogene.

[36]  S. A. Watkins,et al.  Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors. , 2003, Journal of medicinal chemistry.

[37]  P. Bourin,et al.  Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma -irradiation promotes survival. , 2003, Blood.

[38]  I. Weissman,et al.  Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. , 2002, The Journal of clinical investigation.

[39]  Mikhail V. Blagosklonny,et al.  The Restriction Point of the Cell Cycle , 2002, Cell cycle.

[40]  D. Lawrence,et al.  Protection of normal proliferating cells against chemotherapy by staurosporine-mediated, selective, and reversible G(1) arrest. , 2000, Journal of the National Cancer Institute.

[41]  D. Scadden,et al.  Hematopoietic stem cell quiescence maintained by p21cip1/waf1. , 2000, Science.

[42]  P. Leder,et al.  Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  L. Chin,et al.  Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. , 1997, Genes & development.

[44]  K. Helin,et al.  Induction of DNA synthesis and apoptosis are separable functions of E2F-1. , 1997, Genes & development.

[45]  L Meijer,et al.  Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. , 1997, European journal of biochemistry.

[46]  G. Wahl,et al.  DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.

[47]  Stephen J. Elledge,et al.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest , 1994, Cell.

[48]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[49]  E. Sausville,et al.  Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. , 1992, Journal of the National Cancer Institute.

[50]  M. Wick,et al.  In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice. , 1990, Blood.

[51]  G. Kraft,et al.  The formation of radiation-induced DNA breaks: the ratio of double-strand breaks to single-strand breaks. , 1985, International journal of radiation oncology, biology, physics.

[52]  M. Nüsse,et al.  The importance of G1/S-border and mitosis in the fixation of potentially lethal damage , 1983, Radiation and environmental biophysics.

[53]  A. Pardee,et al.  A restriction point for control of normal animal cell proliferation. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Little Repair of Sub-lethal and Potentially Lethal Radiation Damage in Plateau Phase Cultures of Human Cells , 1969, Nature.

[55]  M. Elkind,et al.  Radiation response of mammalian cells grown in culture. VI. Protein, DNA, and RNA inhibition during the repair of x-ray damage. , 1967, Radiation research.

[56]  W. K. Sinclair,et al.  X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. , 1966, Radiation research.

[57]  L. Tolmach,et al.  X-Ray Sensitivity and DNA Synthesis in Synchronous Populations of HeLa Cells , 1963, Science.

[58]  M. Elkind,et al.  Radiation response of mammalian cells grown in culture: III. Modification of X-ray survival of Chinese hamster cells by 5-bromodeoxyuridine , 1963 .

[59]  M. Grenan,et al.  Radioprotection by Mitotic Inhibitors and Mercaptoethylamine , 1961, Science.

[60]  H. Sutton,et al.  Radiation response of mammalian cells grown in culture. 1. Repair of X-ray damage in surviving Chinese hamster cells. , 1960, Radiation research.

[61]  M. M. ELKIND,et al.  X-Ray Damage and Recovery in Mammalian Cells in Culture , 1959, Nature.

[62]  W. W. Smith Protective effect of a colchicine derivative in mice exposed to x-radiation. , 1958, Science.